Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.

NCT05953142 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT05953142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05953142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
Lead sponsor
Federal University of São Paulo
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2024
Completion date
March 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlactatemia, hypoperfusion, sepsis